Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Adrenergic receptor alpha-2A (ADRA2A) |
Target Info
|
Agonist |
[2] |
| References |
Top |
| REF 1 |
Shire Announces NDA Submission of Guanfacine Extended Release for the Treatment of ADHD in Children and Adolescents, 2009. FDA Approved - September 2, 2009
|
| REF 2 |
alpha2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuroscience. 2009 Sep 29;163(1):339-51.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
